Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Combination Product: mavrilimumab
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 41 💬
2MAVRILIMUMAB
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 41, 46 💬
3Mavrilimumab 10 mg
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
4Mavrilimumab 100 mg
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
5Mavrilimumab 150 mg
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
6Mavrilimumab 30 mg
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
7Mavrilimumab 50 mg
(D09930)		1件: Mavrilimumab1件: Mavrilimumab (D09930) 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬